The occurrence of selected hypolipidemic drugs in the aquatic environment

• Autorzy: Rezka P. , Balcerzak W.

Identyfikatory

DOI

10.4467/2353737XCT.15.188.4393

Warianty tytułu

PL

Występowanie wybranych leków hipolipemicznych w środowisku wodnym

• Języki publikacji: EN

Abstrakty

EN

The paper is part of a series of publications discussing the prevalence of pharmaceuticals in the aquatic environment. The paper presents two groups of hypolipidemic drugs (lipid regulators) and their basic parameters. A review of the literature on the occurrence of these compounds in wastewater, surface water and groundwater was made. According to the literature, the presence of various lipid regulators in raw water entering water treatment plants poses a real threat of their penetration into the water supply system, and consequently, to public water intended for human consumption.

PL

Artykuł jest częścią serii publikacji obejmujących zagadnienia występowania farmaceutyków w środowisku wodnym. W pracy przedstawiono dwie grupy leków hipolipemicznych (regulatorów tłuszczu) oraz ich podstawowe parametry. Dokonano przeglądu literatury dotyczącej występowania tych związków w ściekach oraz wodach powierzchniowych i podziemnych. Jak wynika z danych literaturowych, obecność poszczególnych regulatorów tłuszczu w wodzie surowej ujmowanej przez stacje uzdatniania wody stwarza realne zagrożenie ich przenikania do systemu wodociągów, a w następstwie do odbiorców wody przeznaczonej do spożycia.

Słowa kluczowe

EN

lipid regulators; lipid–lowering agents; wastewater; surface water; groundwater; drinking water

PL

regulatory tłuszczu; ścieki; wody powierzchniowe; wody podziemne; woda pitna

• Wydawca: Wydawnictwo Politechniki Krakowskiej im. Tadeusza Kościuszki
• Czasopismo: Czasopismo Techniczne. Środowisko
• Rocznik: 2015
• Tom: Y. 112, iss. 1-Ś
• Strony: 103--110
• Opis fizyczny: Bibliogr. 28 poz., tab., il.

Twórcy

autor

Rezka P.

• Faculty of Environmental Engineering, Cracow University of Technology

autor

Balcerzak W.

• Faculty of Environmental Engineering, Cracow University of Technology

Bibliografia

• [1] Al Aukidy M., Verlicchi P., Voulvoulis N., A framework for the assessment of the environmental risk posed by pharmaceuticals originating from hospital effluents, Science of the Total Environment, Vol. 493, 2014, 54-64.
• [2] Andreozzi R., Raffaele M., Nicklas P., Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment, Chemosphere, Vol. 50, 2003, 1319-1330.
• [3] Balcerzak W., Rezka,P., Occurrence of anti-cancer drugs in the aquatic environment and efficiency of their removal – the selected issues, Technical Transactions, 1-Ś/2014, 11-18.
• [4] Bendz D., Paxeus N.A., Ginn T.R., Loge F.J., Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden, Journal of Hazardous Materials, Vol. 122, 2005, 195-204.
• [5] Benner J., Helbling D.E., Kohler H.-P.E., Wittebol J., Kaiser E., Prassem C., Ternes T.A., Albers C.N., Aamand J., Horemans B., Springael D., Walravens E., Boon N., Is biological treatment a viable alternative for micropollutant removal in drinking water treatment processes?, Water Research, Vol. 47, 2013, 5955-5976.
• [6] Camacho-Munoz D., Martin J., Santos J.L., Aparicio I., Alonso E., Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain), Journal of Hazardous Materials, Vol. 183, 2010, 602-608.
• [7] Fent K., Weston A.A., Caminada D., Ecotoxicology of human pharmaceuticals, Aquatic Toxicology, Vol. 76, 2006, 122-159.
• [8] Grassi M., Rizzo L., Farina A., Endocrine disruptors compounds, pharmaceuticals and personal care products in urban wastewater: implications for agricultural reuse and their removal by adsorption process, Environmental Science and Pollution Research, Vol. 20, 2013, 3616-3628.
• [9] Hernando M.D., Mezcua M., Fernandez–Alba A.R., Barcelo D., Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments, Talanta, Vol. 69, 2006, 334-342.
• [10] Kosma C.I., Lambropoulou D.A., Albanis T.A., Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece, Journal of Hazardous Materials, Vol. 179, 2010, 804-817.
• [11] Luo Y., Guo W., Ngo H.H., Nghiem L.D., Hai F.I., Zhang J., Liang S., Wang X.C., A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment, Science of the Total Environment, Vol. 473-474, 2014, 619-641.
• [12] Martin J., Camacho-Munoz D., Santos J.L., Aparicio I., Alonso E., Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: Removal and ecotoxicological impact of wastewater discharges and sludge disposal, Journal of Hazardous Materials, Vol. 239–240, 2012, 40-47.
• [13] Meffe R., de Bustamante I., Emerging organic contaminants in surface water and groundwater: A first overview of the situation in Italy, Science of the Total Environment, Vol. 481, 2014, 280-295.
• [14] Mompelat S., Le Bot B., Thomas O., Occurrence and fate of pharmaceutical products and by–products, from resource to drinking water, Environment International, Vol. 35, 2009, 803–814.
• [15] Petrie B., Barden R., Kasprzyk-Hodern B., A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring, Water Research, Vol. 72, 2015, 3-27.
• [16] Postigo C., Barcelo D., Synthetic organic compounds and their transformation products in groundwater: Occurrence, fate and mitigation, Science of the Total Environment, Vol. 503–504, 2015, 32-47.
• [17] Rezka P., Balcerzak W., The occurrence of non–steroidal anti–inflammatory drugs in wastewater and water environment and methods of their removal – selected issues, Archives of Waste Management and Environmental Protection, Vol. 17(1), 2015, 33-38.
• [18] Simazaki D., Kubota R., Suzuki T., Akiba M., Nishimura T., Kunikane S., Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health, Water Research, Vol. 76, 2015, 187-200.
• [19] Spongberg A.L., Witter J.D., Acuna J., Vargas J., Murillo M., Umana G., Gomez E., Perez G., Reconnaissance of selected PPCP compounds in Costa Rican surface waters, Water Research, Vol. 45, 2011, 6709-6717.
• [20] Stuart M., Lapworth D., Crane E., HartA., Review of risk from potential emerging contaminants in UK groundwater, Science of the Total Environment, Vol. 416, 2012, 1-21.
• [21] Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barcelo D., Hospital effluent - Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment, Science of the Total Environment, Vol. 430, 2012, 109-118.
• [22] Verlicchi P., Al Aukidy M., Zambello E., Occurrence of pharmaceutical compounds in Urban wastewater: removal, mass load and environmental risk after a secondary treatment ‒ a review, Science of the Total Environment, Vol. 429, 2012, 123-155.
• [23] Vulliet E., Cren-Olive C., Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption, Environmental Pollution, Vol. 159, 2011, 2929-2934.
• [24] Węgrzyn A., Machura M., Żabczyński S., Możliwości usuwania środków cieniujących ze ścieków, Ochrona Środowiska, Vol. 37(1), 2015, 55-63.
• [25] Yu J.T., Bouwer E.J., Coelthan M., Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent, Agricultural Water Management, Vol. 86, 2006, 72-80.
• [26] Yu Y., Wu L., Chang A.C., Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants, Science of the Total Environment, Vol. 442, 2013, 310–316.
• [27] Zejc A., Gorczyca M., Chemia leków, PZWL, Warszawa 2009.
• [28] Drugbank, www.drugbank.ca, online: 22.06.2015.